Setiptiline maleate is a serotonin receptor antagonist. It is classified as a tetracyclic antidepressant (TeCA) and acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). It functions as a norepinephrine reuptake inhibitor, an α2-adrenergic receptor antagonist, and a serotonin receptor antagonist, potentially targeting the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes. Additionally, it acts as an H1 receptor inverse agonist/antihistamine. It is intended for research use only.
- Serotonin receptor antagonist
- Tetracyclic antidepressant (TeCA)
- Noradrenergic and specific serotonergic antidepressant (NaSSA)
- Norepinephrine reuptake inhibitor
- Alpha2-adrenergic receptor antagonist
- Antagonizes serotonin receptor subtypes: 5-HT2A, 5-HT2C, and/or 5-HT3
- H1 receptor inverse agonist/antihistamine
- Purity: 99.94%
- Appearance: Solid
- Color: White to gray